top of page
Search
  • LBF
    • Sep 11, 2023
    • 1 min read

Day One Announces Updated FIREFLY-1 Data for Tovorafenib

Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S. Food and Drug Administration (FDA) for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG). Read more HERE.




34 views0 comments
bottom of page